Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

127.34
+1.150.91%
Volume:2.81M
Turnover:356.67M
Market Cap:221.55B
PE:15.97
High:127.77
Open:125.50
Low:125.49
Close:126.19
Loading ...

2 Top Stocks to Buy Now If You Want Decades of Passive Income

Motley Fool
·
Yesterday

Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Yesterday

Abbott Laboratories Releases 2024 Global Sustainability Report

Reuters
·
31 Jul

Paul MacDonald’s Top Picks for July 29, 2025

Bloomberg
·
30 Jul

The Smartest Dividend Stocks to Buy With $350 Right Now

Motley Fool
·
26 Jul

Brianne Gardner’s Top Picks for July 23, 2025

Bloomberg
·
24 Jul

Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)?

Simply Wall St.
·
23 Jul

Daiwa Securities Adjusts Abbott Laboratories Price Target to $134 From $133, Maintains Outperform Rating

MT Newswires Live
·
22 Jul

Abbott Laboratories: Hold Rating Amid Mixed Performance and Sector Challenges

TIPRANKS
·
21 Jul

Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
19 Jul

Abitare In S.p.A. Strengthens Role in Urban Regeneration

TIPRANKS
·
19 Jul

Abbott Laboratories' Underlying Growth Remains Strong Despite Guidance Cut, RBC Says

MT Newswires Live
·
18 Jul

Abbott price target lowered to $135 from $140 at Mizuho

TIPRANKS
·
18 Jul

Analysts’ Top Healthcare Picks: Jazz Pharmaceuticals (JAZZ), Abbott Laboratories (ABT)

TIPRANKS
·
18 Jul

Abbott Labs Is Maintained at Buy by BTIG

Dow Jones
·
18 Jul

Abbott upgraded to Buy from Hold at Jefferies

TIPRANKS
·
18 Jul

BUZZ-Street View: Abbott's resilient fundamentals, new products to outshine headwinds

Reuters
·
18 Jul

U.S. RESEARCH ROUNDUP-Cintas, Marsh & Mclennan, Netflix

Reuters
·
18 Jul

Abbott Laboratories Reports Strong Q2 2025 Results

TIPRANKS
·
18 Jul

Abbott Laboratories: Temporary Challenges Amid Strong Long-Term Growth Prospects Justify Buy Rating

TIPRANKS
·
18 Jul